Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP

Metabolic Syndrome (MetS) constitutes of metabolic abnormalities that lead to noncommunicable diseases, such as type II diabetes, cardiovascular diseases, and cancer. Early and accurate diagnosis of this abnormality is required to prevent its further progression to these diseases. This paper aims to diagnose the risk of MetS using a new non-clinical approach called "genetically optimized Bayesian adaptive resonance theory mapping" (GOBAM). We evolve the Bayesian adaptive resonance theory mapping (BAM) by using genetic algorithm to optimize the parameters of BAM and its training input sequence. We use the GOBAM algorithm to classify individuals as either being at risk of MetS or not at risk of MetS with a related posterior probability, which ranges between 0 and 1. A data set of 11 237 Malaysians from the CLUSTer study stratified by age and gender into four subcategories was used to evaluate the proposed GOBAM algorithm. The comparative evaluation of our results suggested that the GOBAM performs significantly better than other classical adaptive resonance theory mapping models on the area under the receiver operating characteristic curves (AUC) and others criteria. Our algorithm gives an AUC of 86.42 %, 87.04 %, 91.08 %, and 89.24 % for the young female, middle aged female, young male, and middle-aged male subcategories, respectively. The proposed model can be used to support medical practitioners in accurate and early diagnosis of MetS.